Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 1;21(8):2395-2401.
doi: 10.31557/APJCP.2020.21.8.2395.

Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population

Taqdees Arif  1 , Natasha Anwar  2
Affiliations

Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population

Taqdees Arif et al. Asian Pac J Cancer Prev. .

Abstract

Objective: The purpose of our study was to determine the frequency of BRCA1 promoter hypermethylation and its association with expression changes of BRCA1 and main morphological features in sporadic breast cancer.

Methods: A retrospective review of cases was performed to select those with specific morphological features suggestive of breast cancer. BRCA1 promoter hypermethylation and changes in protein expression were evaluated in 30 cancerous and 30 non-cancerous tissue samples. A tissue microarray containing samples from normal and tumor tissue was prepared and stained for BRCA1 protein expression using a commercially available monoclonal antibody against BRCA1 (Ab-1) clone MS110 (mAb). DNA was extracted using modified protocol of Qiagen minikit. DNA was modified using a Bisulfite conversion kit and BRCA1 hypermethylation was detected using a methylation specific PCR.

Results: Promoter hypermethylation was negative in 30 non-cancerous samples with retained BRCA1 protein expression. Methylation was positive in 82.6% (n=19/23) of the sporadic cancer samples that had loss of BRCA1 expression and 50% (n=2/4) of the samples with equivocal protein expression. Methylation was negative in all the sporadic breast cancer samples (n=3/3) with retained protein expression. Chi-square analysis showed significant association of BRCA1 promoter methylation with decreased protein expression (P=0.016) and co-existence of loss of BRCA1 and Her2neu at chromosome 17 (P=0.026) respectively. There was no significant association of BRCA1 methylation with morphological features excluding necrosis (P=0.035). Promoter hypermethylation was found to be most common (68.75%) among Triple Negative Breast Cancer (TNBC) females less than 45 years old.

Conclusion: Our study suggests that BRCA1 promoter hypermethylation has significant contribution in sporadic breast carcinogenesis. This was our preliminary study in Pakistan. Further studies aimed to determine the in-depth mechanisms of BRCA1 epigenetics in TNBC. BRCAness enriched phenotype in TNBC might be used as a biomarker for the exploitation of therapeutic and clinical implications. <br />.

Keywords: BRCA1 Promoter Hypermethylation; Epigenetics; Sporadic Breast Cancer; triple negative breast cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative BRCA1 IHC Stains. High power (40X) images. A: Retained BRCA1 IHC stain (>10% of tumor nuclei staining), B: Equivocal BRCA1 IHC stain (5%–10% of tumor cell nuclei staining) and C: Loss of BRCA1 (<5% of tumor nuclei staining).
Figure 2
Figure 2
Touchdown MS-PCR Results. (A) Representative image of presence of unmethylated PCR product in cancerous and non-cancerous tissues. (B) and (C) Presence of BRCA1 promoter hypermethylation in sporadic breast cancer patients (with equivocal and loss of BRCA1 protein expression)
See this image and copyright information in PMC

References

    1. Ahmed R, Din HU, Afzal S, et al. Clinicopathological characteristics of triple negative breast cancer. PAFM J. 2017;67:838–42.
    1. Badar F, Mahmood S, Faraz R, et al. Epidemiology of breast cancer at the Shaukat Khanum memorial cancer hospital and research center, Lahore, Pakistan. J Coll Physicians Surg Pak. 2015;25:738–42. - PubMed
    1. Butcher DT, Rodenhiser DI. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. EJC. 2007;43:210–9. - PubMed
    1. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, et al. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res. 2006;8:38. - PMC - PubMed
    1. Chiorean R, Braicu C, Berindan-Neagoe I. Another review on triple negative breast cancer Are we on the right way towards the exit from the labyrinth? Breast J. 2013;22:1026–33. - PubMed